# Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia

> **NCT00627276** · NA · COMPLETED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 16 (actual)

## Conditions studied

- Breast Cancer
- Precancerous Condition

## Interventions

- **DIETARY_SUPPLEMENT:** omega-3 fatty acid
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00627276
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2012-12
- **Final completion:** 2013-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00627276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00627276, "Omega-3 Fatty Acids in Treating Women With Newly Diagnosed Ductal Carcinoma In Situ and/or Atypical Ductal Hyperplasia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00627276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*